MedPath

Establishing age-dependent cut-offs for pathological brain volume loss in the thalamus.

Conditions
G35.1
Registration Number
DRKS00019872
Lead Sponsor
Celgene GmbH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
1100
Inclusion Criteria

MS Patient

Exclusion Criteria

andere Erkrankungen

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Establishing age-dependent cut-offs to distinguish between physiological and pathological brain volume loss in the thalamus.
Secondary Outcome Measures
NameTimeMethod
Confirmation of age-dependent cut-offs to distinguish between physiological and pathological whole brain volume loss
© Copyright 2025. All Rights Reserved by MedPath